197 related articles for article (PubMed ID: 38192435)
1. Patient-Reported Outcomes Measures, Polycystic Kidney Disease Burden, and Outcomes in Autosomal Dominant Polycystic Kidney Disease.
Oberdhan D; Yarlas A; Bjorner JB; Krasa H
Kidney Med; 2024 Jan; 6(1):100755. PubMed ID: 38192435
[TBL] [Abstract][Full Text] [Related]
2. OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD.
Perrone RD; Oberdhan D; Ouyang J; Bichet DG; Budde K; Chapman AB; Gitomer BY; Horie S; Ong ACM; Torres VE; Turner AN; Krasa H
Kidney Int Rep; 2023 May; 8(5):989-1001. PubMed ID: 37180499
[TBL] [Abstract][Full Text] [Related]
3. Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry.
Hoover E; Holliday V; Merullo N; Oberdhan D; Perrone RD; Rusconi C; Park M; Phadnis MA; Thewarapperuma N; Dahl NK
Kidney Med; 2024 May; 6(5):100813. PubMed ID: 38689835
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
Miskulin DC; Abebe KZ; Chapman AB; Perrone RD; Steinman TI; Torres VE; Bae KT; Braun W; Winklhofer FT; Hogan MC; Rahbari-Oskoui F; Moore CG; Flessner MF; Schrier RW;
Am J Kidney Dis; 2014 Feb; 63(2):214-26. PubMed ID: 24183837
[TBL] [Abstract][Full Text] [Related]
5. Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
Messchendorp AL; Meijer E; Visser FW; Engels GE; Kappert P; Losekoot M; Peters DJM; Gansevoort RT;
Am J Nephrol; 2019; 50(5):375-385. PubMed ID: 31600749
[TBL] [Abstract][Full Text] [Related]
6. Tolvaptan and Kidney Function Decline in Older Individuals With Autosomal Dominant Polycystic Kidney Disease: A Pooled Analysis of Randomized Clinical Trials and Observational Studies.
Chebib FT; Zhou X; Garbinsky D; Davenport E; Nunna S; Oberdhan D; Fernandes A
Kidney Med; 2023 Jun; 5(6):100639. PubMed ID: 37250503
[TBL] [Abstract][Full Text] [Related]
7. Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
Yu ASL; Shen C; Landsittel DP; Harris PC; Torres VE; Mrug M; Bae KT; Grantham JJ; Rahbari-Oskoui FF; Flessner MF; Bennett WM; Chapman AB;
Kidney Int; 2018 Mar; 93(3):691-699. PubMed ID: 29290310
[TBL] [Abstract][Full Text] [Related]
8. Rationale and study protocol of ACQUIRE, a prospective, observational study measuring quality of life, treatment preference and treatment satisfaction of autosomal dominant polycystic kidney disease (ADPKD) patients in Europe.
Joly D; Quinn J; Mokiou S; O'Reilly K; Sánchez-Covisa J; Wang-Silvanto J; Doll H
BMC Nephrol; 2020 Jul; 21(1):298. PubMed ID: 32709218
[TBL] [Abstract][Full Text] [Related]
9. Kidney Energetics and Cyst Burden in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study.
Bjornstad P; Richard G; Choi YJ; Nowak KL; Steele C; Chonchol MB; Nadeau KJ; Vigers T; Pyle L; Tommerdahl K; van Raalte DH; Hilkin A; Driscoll L; Birznieks C; Hopp K; Wang W; Edelstein C; Nelson RG; Gregory AV; Kline TL; Blondin D; Gitomer B
Am J Kidney Dis; 2024 Apr; ():. PubMed ID: 38621633
[TBL] [Abstract][Full Text] [Related]
10. Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument.
Oberdhan D; Cole JC; Krasa HB; Cheng R; Czerwiec FS; Hays RD; Chapman AB; Perrone RD
Am J Kidney Dis; 2018 Feb; 71(2):225-235. PubMed ID: 29150246
[TBL] [Abstract][Full Text] [Related]
11. RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study.
Ryu H; Park HC; Oh YK; Sangadi I; Wong A; Mei C; Ecder T; Wang AY; Kao TW; Huang JW; Rangan GK; Ahn C
BMJ Open; 2020 Feb; 10(2):e034103. PubMed ID: 32034027
[TBL] [Abstract][Full Text] [Related]
12. Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.
Chapman AB; Bost JE; Torres VE; Guay-Woodford L; Bae KT; Landsittel D; Li J; King BF; Martin D; Wetzel LH; Lockhart ME; Harris PC; Moxey-Mims M; Flessner M; Bennett WM; Grantham JJ
Clin J Am Soc Nephrol; 2012 Mar; 7(3):479-86. PubMed ID: 22344503
[TBL] [Abstract][Full Text] [Related]
13. Baseline characteristics of the autosomal-dominant polycystic kidney disease sub-cohort of the KoreaN cohort study for outcomes in patients with chronic kidney disease.
Kim H; Koh J; Park SK; Oh KH; Kim YH; Kim Y; Ahn C; Oh YK
Nephrology (Carlton); 2019 Apr; 24(4):422-429. PubMed ID: 29797773
[TBL] [Abstract][Full Text] [Related]
14. Serum bicarbonate is associated with kidney outcomes in autosomal dominant polycystic kidney disease.
Blijdorp CJ; Severs D; Musterd-Bhaggoe UM; Gansevoort RT; Zietse R; Hoorn EJ;
Nephrol Dial Transplant; 2021 Dec; 36(12):2248-2255. PubMed ID: 33377160
[TBL] [Abstract][Full Text] [Related]
15. Association between urinary biomarkers and disease progression in adults with autosomal dominant polycystic kidney disease.
Segarra-Medrano A; Martin M; Agraz I; Vilaprinyó M; Chamoun B; Jatem E; Molina M; Colàs-Campàs L; Garcia-Carrasco A; Roche S
Clin Kidney J; 2020 Aug; 13(4):607-612. PubMed ID: 32905289
[TBL] [Abstract][Full Text] [Related]
16. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
Kline TL; Korfiatis P; Edwards ME; Bae KT; Yu A; Chapman AB; Mrug M; Grantham JJ; Landsittel D; Bennett WM; King BF; Harris PC; Torres VE; Erickson BJ;
Kidney Int; 2017 Nov; 92(5):1206-1216. PubMed ID: 28532709
[TBL] [Abstract][Full Text] [Related]
17. The correlation between kidney volume and measured glomerular filtration rate in an Asian ADPKD population: a prospective cohort study.
Phakdeekitcharoen B; Treesinchai W; Wibulpolprasert P; Boongird S; Klytrayong P
BMC Nephrol; 2021 May; 22(1):178. PubMed ID: 33992075
[TBL] [Abstract][Full Text] [Related]
18. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
[TBL] [Abstract][Full Text] [Related]
19. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.
Irazabal MV; Rangel LJ; Bergstralh EJ; Osborn SL; Harmon AJ; Sundsbak JL; Bae KT; Chapman AB; Grantham JJ; Mrug M; Hogan MC; El-Zoghby ZM; Harris PC; Erickson BJ; King BF; Torres VE;
J Am Soc Nephrol; 2015 Jan; 26(1):160-72. PubMed ID: 24904092
[TBL] [Abstract][Full Text] [Related]
20. Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases.
Higashihara E; Yamamoto K; Kaname S; Okegawa T; Tanbo M; Yamaguchi T; Shigemori K; Miyazaki I; Yokoyama K; Nutahara K
Clin Exp Nephrol; 2019 Jan; 23(1):100-111. PubMed ID: 30097754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
